129 related articles for article (PubMed ID: 12526157)
1. Construction of multiply disabled herpes simplex viral vectors for gene delivery to the nervous system.
Lilley CE; Coffin RS
Methods Mol Med; 2003; 76():33-49. PubMed ID: 12526157
[No Abstract] [Full Text] [Related]
2. Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo.
Lilley CE; Groutsi F; Han Z; Palmer JA; Anderson PN; Latchman DS; Coffin RS
J Virol; 2001 May; 75(9):4343-56. PubMed ID: 11287583
[TBL] [Abstract][Full Text] [Related]
3. Use of the herpes simplex viral genome to construct gene therapy vectors.
Burton EA; Huang S; Goins WF; Glorioso JC
Methods Mol Med; 2003; 76():1-31. PubMed ID: 12526156
[No Abstract] [Full Text] [Related]
4. Cellular Antisilencing Elements Support Transgene Expression from Herpes Simplex Virus Vectors in the Absence of Immediate Early Gene Expression.
Han F; Miyagawa Y; Verlengia G; Ingusci S; Soukupova M; Simonato M; Glorioso JC; Cohen JB
J Virol; 2018 Sep; 92(17):. PubMed ID: 29950408
[TBL] [Abstract][Full Text] [Related]
5. Development and optimization of herpes simplex virus vectors for multiple long-term gene delivery to the peripheral nervous system.
Palmer JA; Branston RH; Lilley CE; Robinson MJ; Groutsi F; Smith J; Latchman DS; Coffin RS
J Virol; 2000 Jun; 74(12):5604-18. PubMed ID: 10823868
[TBL] [Abstract][Full Text] [Related]
6. Herpes simplex amplicon vectors.
Link CJ; Vahanian NN; Wang S
Methods Mol Med; 2003; 76():61-87. PubMed ID: 12526159
[No Abstract] [Full Text] [Related]
7. Herpes simplex viral vectors for therapeutic gene delivery to ocular tissues. Recent breakthroughs in the molecular genetics of ocular diseases.
Pepose JS; Leib DA
Invest Ophthalmol Vis Sci; 1994 May; 35(6):2662-6. PubMed ID: 8188460
[No Abstract] [Full Text] [Related]
8. The use of herpes simplex virus-based vectors for gene delivery to the nervous system.
Lachmann RH; Efstathiou S
Mol Med Today; 1997 Sep; 3(9):404-11. PubMed ID: 9302691
[TBL] [Abstract][Full Text] [Related]
9. Herpes simplex virus type 1 promoter activity during latency establishment, maintenance, and reactivation in primary dorsal root neurons in vitro.
Arthur JL; Scarpini CG; Connor V; Lachmann RH; Tolkovsky AM; Efstathiou S
J Virol; 2001 Apr; 75(8):3885-95. PubMed ID: 11264377
[TBL] [Abstract][Full Text] [Related]
10. Gene transfer to neurons using herpes simplex virus-based vectors.
Fink DJ; DeLuca NA; Goins WF; Glorioso JC
Annu Rev Neurosci; 1996; 19():265-87. PubMed ID: 8833444
[TBL] [Abstract][Full Text] [Related]
11. Replication-defective genomic herpes simplex vectors: design and production.
Burton EA; Bai Q; Goins WF; Glorioso JC
Curr Opin Biotechnol; 2002 Oct; 13(5):424-8. PubMed ID: 12459332
[TBL] [Abstract][Full Text] [Related]
12. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.
Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA
Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115
[TBL] [Abstract][Full Text] [Related]
13. Construction of replication-defective herpes simplex virus vectors.
Goins WF; Marconi P; Krisky D; Wolfe D; Glorioso JC; Ramakrishnan R; Fink DJ
Curr Protoc Hum Genet; 2002 Aug; Chapter 12():Unit 12.11. PubMed ID: 18428322
[TBL] [Abstract][Full Text] [Related]
14. Sustained FXN expression in dorsal root ganglia from a nonreplicative genomic HSV-1 vector.
Ventosa M; Wu Z; Lim F
J Gene Med; 2017 Nov; 19(11):376-386. PubMed ID: 29044877
[TBL] [Abstract][Full Text] [Related]
15. Herpes simplex virus vectors for the nervous system.
Lilley CE; Branston RH; Coffin RS
Curr Gene Ther; 2001 Nov; 1(4):339-58. PubMed ID: 12109061
[TBL] [Abstract][Full Text] [Related]
16. Development and optimization of adeno-associated virus vector transfer into the central nervous system.
During MJ; Young D; Baer K; Lawlor P; Klugmann M
Methods Mol Med; 2003; 76():221-36. PubMed ID: 12526166
[No Abstract] [Full Text] [Related]
17. The herpes simplex virus type 1 ICP0 promoter is activated by viral reactivation stimuli in trigeminal ganglia neurons of transgenic mice.
Loiacono CM; Taus NS; Mitchell WJ
J Neurovirol; 2003 Jun; 9(3):336-45. PubMed ID: 12775417
[TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus mediated nerve growth factor expression in bladder and afferent neurons: potential treatment for diabetic bladder dysfunction.
Goins WF; Yoshimura N; Phelan MW; Yokoyama T; Fraser MO; Ozawa H; Bennett N JR; de Groat WC; Glorioso JC; Chancellor MB
J Urol; 2001 May; 165(5):1748-54. PubMed ID: 11342969
[TBL] [Abstract][Full Text] [Related]
19. Regulable Transgene Expression in Dorsal Root Ganglia of a Replication-Defective Herpes Simplex Virus Type 1 Vector by Means of Sciatic Nerve Injection.
Chen B; Yao F; Guo L
Plast Reconstr Surg; 2016 Feb; 137(2):331e-338e. PubMed ID: 26818323
[TBL] [Abstract][Full Text] [Related]
20. An HSV-1 containing the rat beta-glucuronidase cDNA inserted within the LAT gene is less efficient than the parental strain at establishing a transcriptionally active state during latency in neurons.
Deshmane SL; Valyi-Nagy T; Block T; Maggioncalda J; Wolfe JH; Dillner A; Fraser NW
Gene Ther; 1995 May; 2(3):209-17. PubMed ID: 7614252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
